Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
BGB-A317-ZW25-101
Active, not recruiting
Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab
Beigene Study ID
BGB-A317-ZW25-101
ClinicalTrials.gov ID
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents